Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Nestlé Health Science

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 15
Average round size
info
The average size of a deal this fund participated in
$56M
Portfolio companies 8
Rounds per year 1.15
Lead investments 5
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.47
Exits 2
Key employees 1

Areas of investment

  • Health Care
  • Biotechnology
  • Life Science
  • Biopharma
  • Drug Discovery
Summary

In 2011 was created Nestlu00e9 Health Science, which is appeared as Corporate Investor. The venture was found in Europe in Switzerland. The leading representative office of defined Corporate Investor is situated in the Vevey.

The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Nestlu00e9 Health Science, startups are often financed by Flagship Pioneering, Seventure Partners, Lundbeckfonden Ventures. The meaningful sponsors for the fund in investment in the same round are Seventure Partners, Lundbeckfonden Ventures, Principia SGR. In the next rounds fund is usually obtained by Seventure Partners, Principia SGR, Omnes Capital.

This Nestlu00e9 Health Science works on 9 percentage points more the average amount of lead investments comparing to the other organizations. The common things for fund are deals in the range of 50 - 100 millions dollars. The fund is constantly included in less than 2 deals per year. The top amount of exits for fund were in 2019. The real fund results show that this Corporate Investor is 42 percentage points more often commits exit comparing to other companies. The top activity for fund was in 2016.

Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight ENTEROME Bioscience, Seres Health, Axcella. The fund has no exact preference in some founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. Among the most popular fund investment industries, there are Life Science, Therapeutics. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Nestlé Health Science:
Typical Co-investors
Nestlé Health Science is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Nestlé Health Science:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
DRL Capital -
F+ Ventures Istanbul, Istanbul, Turkey
Federated Kaufmann Fund -
Hillman Ventures Pennsylvania, Pittsburgh, United States
IXOLIT Austria, Vienna
k16 Ventures Berlin, Berlin, Germany
Mamacrowd Italy, Lombardy, Milan
MassAve Global New York, New York, United States
Montis Capital Boulder, Colorado, United States
OS Fund Illinois, Park Ridge, United States
Pale Blue Dot Malmö, Skane Lan, Sweden
RSE Ventures New York, New York, United States
S-UBG Group Aachen, Germany, Nordrhein-Westfalen
SD Skytech -
Thorndale Farm Batavia, New York, United States
Tsadik Foundation -
UK Innovation & Science Seed Fund Harwell, Oxfordshire, United Kingdom
Vermillion Capital Minneapolis, Minnesota, United States
Wit SoundView Ventures New York, New York, United States
Zephyr Acorn Kenya, Nairobi, Nairobi Area

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

ENTEROME

Biopharma
Biotechnology
Drug Discovery
Health Care
Life Science
$17M20 Apr 2016 Ile-de-France

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Nestlé Health Science?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 15
Average round size 56M
Rounds per year 1.15
Peak activity year 2016
Lead investments 5
Follow on index 0.47
Exits 2
Group Appearance index 0.40

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

ENTEROME

Biopharma
Biotechnology
Drug Discovery
Health Care
Life Science
$17M20 Apr 2016 Ile-de-France
Crunchbase icon

Content report

The following text will be sent to our editors: